|

Genomics and Prognosis in GI Cancers

RECRUITINGSponsored by National Health Research Institutes, Taiwan
Actively Recruiting
SponsorNational Health Research Institutes, Taiwan
Started2020-04-15
Est. completion2024-12-31
Eligibility
Age20 Years+
View on ClinicalTrials.gov →

NCT05767697

Summary

This study aims to collect biospecimens and explore the correlation of genomics and prognosis in alimentary tract cancers.

Eligibility

Age: 20 Years+
Inclusion Criteria:

* Able to sign the informed consent
* Age \>= 20
* Histology proved pancreatic cancer, esophageal cancer, gastric cancer, hepatocellular carcinoma, cholangiocarcinoma, colorectal cancer
* Agree to provide tumor/normal tissue including but not limited to surgical specimen, biopsy, cytology specimen, bile, urine or stool
* Agree to receive blood sampling 20ml at first time and 10ml during each follow-up (total sampling amount no more than 30ml per month)

Exclusion Criteria:

* Cannot cooperate with blood sampling

Conditions4

CancerGI CancerLiver CancerLiver Disease

Browse More Trials

Cancer trialsLiver Disease trialsLiver Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.